Takeda Pharmaceutical Company Limited 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 11:50 am Sale | 2022-06-21 | 13G | OVID THERAPEUTICS INC OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 0 0.000% | -8,781,996 (Position Closed) | Filing |